NCARDIA

In News

Ncardia - 2026 Funding Rounds & List of Investors - Tracxn

Tracxn - Aug 25, 2026

Ncardia inks $60M funding deal to expand discovery and commercial production services for stem cells - Fierce Biotech

Fierce Biotech - Nov 16, 2021

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates - BioInformant

BioInformant - Sep 10, 2024

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes - Business Wire

Business Wire - Jan 21, 2020

Ncardia Expands iPSC Manufacturing and Phenotypic Drug Discovery Services With Support From Investors - PR Newswire

PR Newswire - Jul 15, 2019

New platform to accelerate cardiac drug development - LUMC

LUMC - Jan 22, 2026

An ethical shift in NHP research: iPSC-derived cardiomyocytes for safer pharmacology - drugtargetreview.com

drugtargetreview.com - Oct 06, 2025

On back of Roche pact, newly formed Ncardia wins iPSC deal with Evotec - Fierce Biotech

Fierce Biotech - Dec 06, 2017

Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BioInformant

BioInformant - Apr 26, 2022

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings - Business Wire

Business Wire - Nov 16, 2021

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine - dutchnews.nl

dutchnews.nl - Jan 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment